OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
Portfolio Pulse from
OrthoPediatrics Corp. reported a record full year 2024 revenue of $204.7 million, marking a 38% increase compared to the previous year. The company also more than doubled its fourth quarter 2024 adjusted EBITDA.
March 04, 2025 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OrthoPediatrics Corp. reported a significant 38% increase in full year 2024 revenue to $204.7 million and more than doubled its Q4 adjusted EBITDA, indicating strong financial performance.
The substantial increase in revenue and EBITDA suggests strong operational performance and growth potential, likely leading to positive investor sentiment and a potential rise in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100